News
Chiesi fills permanent CEO role with Flagship's Khougazian
Chiesi has named Flagship's David Khougazian as its new permanent chief executive, following the departure of Giuseppe Accogli earlier this year.
News
WCLC: Lung cancer news from BioNTech, Akeso, and Roche
As the World Conference on Lung Cancer (WCLC) draws to a close, here are some late-breaking clinical trial data that made waves at the congress.
News
GSK showcases positive data with lung cancer drugs at WCLC
New data at WCLC26 could push GSK's ROS1+ NSCLC drug Jideytro into the first-line setting, while B7-H3-targeted ADC ris-rez extends survival in SCLC.
R&D
Changing Faces: Pharma and biotech hires, August 2026
August brought another wave of leadership changes across biotech, pharma, and research organisations.
News
AZ's Etcamah falls short in first-line breast cancer trial
A week after getting FDA approval for frontline breast cancer treatment, AstraZeneca's Etcamah missed the mark in a trial aiming to expand its label.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
